Company facts
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Santa Clara, California
- Most recent report
- 8-K, filed Sep 8, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 1090872
- Fiscal year ends
- October
- Filer status
- Large accelerated filer
Financials 8 of 40
News 8 of 108
Prospectuses and Registrations 8 of 24
- 424B3 Prospectus supplement for an offering Sep 23, 2026
- S-4 Registration statement for a merger or exchange Sep 1, 2026
- S-3ASR Automatic shelf registration Sep 1, 2026
- 424B5 Prospectus supplement for an offering Sep 6, 2024
- FWP Free writing prospectus Sep 4, 2024
- 424B5 Prospectus supplement for an offering Sep 4, 2024
- S-3ASR Automatic shelf registration Sep 3, 2024
- 424B5 Prospectus supplement for an offering Mar 5, 2021
Proxies 8 of 25
- DEFA14A Extra proxy material Feb 6, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 6, 2026
- PRE 14A Preliminary proxy statement Jan 23, 2026
- DEFA14A Extra proxy material Feb 21, 2025
- DEFA14A Extra proxy material Jan 31, 2025
- DEF 14A Proxy statement for a shareholder vote Jan 31, 2025
- PRE 14A Preliminary proxy statement Jan 14, 2025
- DEF 14A Proxy statement for a shareholder vote Feb 2, 2024
Ownership 8 of 788
- 4 Insider reported a trade Sep 10, 2026
- 3 Insider reported their initial holding Sep 10, 2026
- 4 Insider reported a trade Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 4 Insider reported a trade Jun 29, 2026
- 3 Insider reported their initial holding Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 2, 2026
Other 8 of 16
- EFFECT Notice that a registration became effective Sep 23, 2026
- SD Conflict minerals disclosure May 29, 2026
- ARS Annual report sent to shareholders Feb 6, 2026
- SD Conflict minerals disclosure May 27, 2025
- ARS Annual report sent to shareholders Jan 31, 2025
- SD Conflict minerals disclosure May 28, 2024
- ARS Annual report sent to shareholders Feb 2, 2024
- SD Conflict minerals disclosure May 24, 2023
What to read: Jul 2026 10-Q
SECSift found 2 of 11 sections worth reading, with 4 positive, 6 notable, and 0 negative flags.
Financial Statements (Item 1)
Core financial results, acquisition, and debt issuance; all material.Management's Discussion (Item 2)
Many specific financial results, acquisitions, debt, restructuring, tariff impacts.Positive- Net revenue up 8% in Q3 and 9M 2026; net income $362M (Q3) and $1,006M (9M).
- Cash from operations increased to $1,064M in 9M 2026 from $1,014M in 9M 2025.
- Gross margin up 4ppts in Q3 to 55.5% and 2ppts in 9M to 54.0% vs prior year.
- Operating margin up 3ppts in Q3 to 23.6% and 1ppt in 9M to 21.7% vs prior year.
Notable- Acquired Biocare for $950M net cash on June 24, 2026, expanding pathology portfolio.
- Issued $600M 4.90% senior notes due 2032 on June 25, 2026.
- Two restructuring plans (FY25 $109M, FY26 $15M) aim for combined $120-130M annual savings.
- Tariff refunds contributed ~1ppt to Q3 operating margin improvement.
- Inventory days on hand rose to 120 from 107 due to strategic tariff-mitigation purchases.
What changed: Jul 2026 vs. Apr 2026
About 8% of A's Jul 2026 10-Q is new information. 35 paragraphs were added, 235 changed, and 46 removed. Below are the most important lines SECSift identified.
New
Changed
- Total debt rose to $3.9B from $3.4B; senior notes rose to $3.9B from $3.3B as of July 31, 2026.
- Weighted average price paid rose to $127.24 from $118.90 per share.
- Remaining buyback authorization fell to $1,654 million from $1,732 million.
- Changed from no receivable to submitting additional IEEPA tariff refund claims; recoverability uncertain.
- Exhibit 10.1 replaced prior 10.1 (Transition Agreement) and 10.2 (Letter of Terms) with Deferred Compensation Plan effective 2024.
- Principal Accounting Officer signature changed from Rodney Gonsalves to Timothy C. Downs.
- Submitted additional IEEPA tariff refund claims; recognized net benefit of 1 ppt to Q3 operating margin.
- Total shares repurchased rose to 612,270 from 550,000 in the quarterly period ended July 31, 2026.
Everything here comes from Agilent Technologies, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Sep 1, 2026, from the 10-Q for Jul 2026.